BAD HOMBURG/KONSTANZ, GERMANY -- (MARKET WIRE) -- October 25, 2006 -- ALTANA AG (NYSE: AAA) (FRANKFURT: ALT) announced today that the U.S. Food and Drug Administration (FDA) has granted marketing approval for OMNARIS™ (Ciclesonide nasal spray), 200µg once-daily.
